BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3063934)

  • 1. [The most frequent sites of origin of squamous cell carcinoma of the oral cavity and oropharynx. Interpretative hypothesis].
    Gandolfo S; Bobba V
    Minerva Stomatol; 1988 Oct; 37(10):751-5. PubMed ID: 3063934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution of sites of cancers of the mouth cavity and oropharynx].
    Kühn AG; Küter E; Lamprecht J
    Laryngorhinootologie; 1990 Jan; 69(1):13-5. PubMed ID: 2155619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicentric cancer spread in the mouth cavity and oropharynx].
    Brandau P; Glanz H
    HNO; 1989 Dec; 37(12):485-9. PubMed ID: 2606739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunogold-silver technic in detecting cellular nucleic acids and antigens in squamous epithelial cancers].
    Henke RP; Claviez A; Löning T; Rutter G; Milde-Langosch K
    Acta Histochem Suppl; 1989; 37():73-8. PubMed ID: 2505324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
    Rohrmeier M; Langnickel R; Hilpert P
    HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility of DNA impulse cytophotometry (ICP) in the diagnosis of squamous cell cancers of the oral cavity and oropharynx].
    Adler D; Feichter GE; Maier H
    Laryngol Rhinol Otol (Stuttg); 1986 Apr; 65(4):187-90. PubMed ID: 3713395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing the therapy-dependent prognosis index (TPI) of DOSAK with patients from the Hospital for Oral Surgery in Halle].
    Tischendorf L; Schubert J; Grimm G
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(1):65-9. PubMed ID: 3858042
    [No Abstract]   [Full Text] [Related]  

  • 8. Microvascular invasion in cancer of the oral cavity and oropharynx.
    Close LG; Burns DK; Reisch J; Schaefer SD
    Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1191-5. PubMed ID: 3663346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: a study of surgical margins.
    Lee JG
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(1):ORL49-53. PubMed ID: 4813646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phalangette metastases of cancer of the mouth. An uncommon mode of propagation].
    Vanel D; Luboinski B; Micheau C; Wibault P; Masselot J
    J Radiol; 1990 Mar; 71(3):237, 244. PubMed ID: 2352216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of squamous cell carcinoma of the oral cavity and oral pharynx: part II.
    Bergman SA; Elias EG
    J Md State Dent Assoc; 1982 Apr; 25(1):21-3. PubMed ID: 6951903
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Introduction to the "Prospective DOSAK Study on Squamous Cell Carcinoma of the Lips, the Oral Cavity and the Oropharynx"].
    Platz H; Fries R; Hudec M
    Dtsch Z Mund Kiefer Gesichtschir; 1988; 12(4):293-302. PubMed ID: 3240611
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simultaneous squamous cell carcinomas of the oral cavity and oropharynx].
    Ricard AS; Majoufre-Lefebvre C; Demeaux H; Siberchicot F; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):509-12. PubMed ID: 17881023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ORL brachytherapy. Focus on brachytherapy for squamous cell carcinoma of the oral cavity and pharynx].
    Mazeron JJ
    Bull Cancer Radiother; 1995; 82(2):179-85. PubMed ID: 7546888
    [No Abstract]   [Full Text] [Related]  

  • 16. Microvascular invasion and survival in cancer of the oral cavity and oropharynx.
    Close LG; Brown PM; Vuitch MF; Reisch J; Schaefer SD
    Arch Otolaryngol Head Neck Surg; 1989 Nov; 115(11):1304-9. PubMed ID: 2803710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx.
    Tschopp L; Nuyens M; Stauffer E; Krause T; Zbären P
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):99-102. PubMed ID: 15632917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma.
    Woolgar JA
    Oral Oncol; 2006 Mar; 42(3):229-39. PubMed ID: 16150633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumours of the oral cavity, pharynx, oesophagus and stomach.
    Leininger JR; Jokinen MP
    IARC Sci Publ; 1994; (111):167-93. PubMed ID: 8082906
    [No Abstract]   [Full Text] [Related]  

  • 20. Masseter muscle cross over flap in primary closure of oral-oropharyngeal defects.
    Tiwari R
    J Laryngol Otol; 1987 Feb; 101(2):172-8. PubMed ID: 3572220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.